Recording sheets containing pyrrole, pyrrolidine, pyridine, piperidine, homopiperidine, quinoline, isoquinoline, quinuclidine, indole, and indazole compounds

Abstract: Disclosed is a recording sheet which comprises a substrate and an additive material selected from the group consisting of pyrrole compounds, pyrrolidine compounds, pyridine compounds, piperidine compounds, homopiperidine compounds, quinoline compounds, isoquinoline compounds, quinuclidine compounds, indole compounds, indazole compounds, and mixtures thereof.

Description: The present invention is directed to recording sheets, such as transparency materials, filled plastics, papers, and the like. More specifically, the present invention is directed to recording sheets particularly suitable for use in ink jet printing processes. US-A-5,006,407 discloses a transparency comprised of a supporting substrate and a hydrophilic coating comprising a plasticizer and a member selected from various cellulose compounds, acrylamide and poly(alkylene oxide) and mixture thereof. JP-A-61277484 discloses a recording layer comprising a cationic compound or amine compound of a specific formula on a base to produce an ink jet recording material. One of the disclosed amine compounds comprises two moieties which are cyclic groups having five carbon atoms and one nitrogen atom. EP-A-0557990 discloses a recording medium for a sublimation type heat-sensitive transfer recording process, wherein an image receiving layer comprising a resin composition containing dyeable resin and at least one phosphite antioxidant, is formed on a substrate. Additionally, specific photostabilisers are disclosed among which there are compounds containing a piperidyl group. US-A-4987049 discloses an image-receiving element for which a heat transfer type dye image, which comprises a support, a binder and a compound which is a complex made from a transition metal ion and a coordination compound. The coordination compound is being selected from a group consisting of various nitrogen containing compounds among which there are also pyridine compounds. While known compositions and processes are suitable for their intended purposes, a need remains for improved recording sheets. In addition, there is a need for improved recording sheets suitable for use in ink jet printing processes. Further, a need remains for recording sheets which exhibit rapid drying times when imaged with aqueous inks. Additionally, there is a need for recording sheets which enable precipitation of a dye from a liquid ink onto the sheet surface during printing processes. A need also remains for recording sheets which are particularly suitable for use in printing processes wherein the recorded substrates are imaged with liquid inks and dried by exposure to microwave radiation. Further, there is a need for recording sheets coated with a discontinuous, porous film. There is also a need for recording sheets which, subsequent to being imaged with an aqueous ink, exhibit reduced curling. It is an object of the present invention to provide recording sheets with the above noted advantages. These and other objects of the present invention (or specific embodiments thereof) can be achieved by providing a recording sheet which comprises a substrate and a material selected from the group consisting of pyrrole compounds, pyrrolidine compounds, pyridine compounds, piperidine compounds, homopiperidine compounds, quinoline compounds, isoquinoline compounds, quinuclidine compounds, indole compounds, indazole compounds, and mixtures thereof as claimed in claim 1. Another embodiment of the present invention is directed to a recording sheet which consists essentially of a substrate, at least one material selected from the group consisting of pyrrole compounds, pyrrolidine compounds, pyridine compounds, piperidine compounds, homopiperidine compounds, quinoline compounds, isoquinoline compounds, quinuclidine compounds, indole compounds, indazole compounds, and mixtures thereof, an optional binder, an optional antistatic agent, an optional biocide, and an optional filler as claimed in claim 2. The recording sheets of the present invention comprise a substrate and at least one material selected from the group consisting of pyrrole compounds, pyrrolidine compounds, pyridine compounds, piperidine compounds, homopiperidine compounds, quinoline compounds, isoquinoline compounds, quinuclidine compounds, indole compounds, indazole compounds, and mixtures thereof as claimed in claim 1. Any suitable substrate can be employed. Examples include transparent materials, such as polyester, including Mylar™, and the like, with polyester such as Mylar™ being preferred in view of its availability and relatively low cost. The substrate can also be opaque, including opaque plastics, such as Teslin™, available from PPG Industries, and filled polymers, such as Melinex®, available from ICI. Filled plastics can also be employed as the substrate, particularly when it is desired to make a "never-tear paper" recording sheet. Paper is also suitable, including plain papers such as Xerox® 4024, diazo papers, or the like. Other suitable substrates are mentioned in U.S. application S.N. 08/196,676, (a divisional application thereof has issued as US-Patent 5,657,064). The substrate can be of any effective thickness. Typical thicknesses for the substrate are from about 50 to about 500 µm, and preferably from about 100 to about 125 µm, although the thickness can be outside these ranges. Situated on the substrate of the present invention is a material selected from the group consisting of pyrrole compounds, pyrrolidine compounds, pyridine compounds, piperidine compounds, homopiperidine compounds, quinoline compounds, isoquinoline compounds, quinuclidine compounds, indole compounds, indazole compounds, and mixtures thereof. Pyrrole compounds generally are those of the general formula wherein R 1 , R 2 , R 3 , R 4 , and R 5 each, independently of one another, can be (but are not limited to) hydrogen, alkyl, substituted alkyl (such as alkyl carboxyl, alkyl vinyl, alkyl hydroxyl, carbonyl alkyl piperazine, alkyl halide, alkyl pyrrolidinyl, or the like), hydroxyl, carboxyl, amide, oxo, alkoxy, aldehyde, acetyl, carbonyl alkyl piperazine, acetyl, amino, alkylene, ammonium thio carbamate, ester, arylalkyl, substituted arylalkyl (such as benzyl halide or the like), vinyl, or the like. Pyrrolidine compounds generally are those of the general formula wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 each, independently of one another, can be (but are not limited to) hydrogen, alkyl, substituted alkyl (such as alkyl carboxyl, alkyl vinyl, alkyl hydroxyl, carbonyl alkyl piperazine, alkyl halide, alkyl pyrrolidinyl, or the like), hydroxyl, carboxyl, amide, oxo, alkoxy, aldehyde, acetyl, carbonyl alkyl piperazine, acetyl, amino, alkylene, ammonium thio carbamate, ester, arylalkyl, substituted arylalkyl (such as benzyl halide or the like), vinyl, or the like. Other variations are also possible, such as a double bond between one of the ring carbon atoms and another atom, such as carbon, oxygen, or the like. Examples of pyrrole compounds and pyrrolidine compounds include (1) 2-acetylpyrrole (Aldrich 24,735-9), of the formula: (2) 2-acetyl-1-methylpyrrole (Aldrich 16,086-5), of the formula: (3) 3-acetyl-1-methylpyrrole (Aldrich 30,986-9), of the formula: (4) 3-acetyl-2,4-dimethylpyrrole (Aldrich A1,480-4), of the formula: (5) pyrrole-2-carboxaldehyde (Aldrich P7,340-4), of the formula: (6) pyrrole-2-carboxylic acid (Aldrich P7,360-9), of the formula: (7) 3-carboxy-1,4-dimethyl-2-pyrroleacetic acid (Aldrich 31,625-3), of the formula: (8) L-proline amide (Aldrich 28,705-9), of the formula: (9) proline(Aldrich 13,154-7; 17,182-4; 85,891-9), of the formula: (10) 1-(pyrrolidino carbonylmethyl) piperazine (Aldrich 19,783-1), of the formula: (11) 2-pyrrolidone-5-carboxylic acid (Aldrich P7,520; 29,291-5), of the formula: (12) 3-pyrrolidino-1,2-propane diol (Aldrich 21,851-0), of the formula: (13) 4-hydroxy-L-proline (Aldrich H5,440-9; 21,994-0; 21,995-9), of the formula: (14) 1,1'-ethylene bis (5-oxo-3-pyrrolidine carboxylic acid) (Aldrich 32,756-5), of the formula: (15) kainic acid monohydrate (2-carboxy-4-isopropenyl-3-pyrrolidine acetic acid monohydrate) (Aldrich 28,634-6), of the formula: and the like. The general groups of pyrrole and pyrrolidine compounds encompass pyrrole and pyrrolidine acid salt compounds, which are of the same general formulae as pyrrole and pyrrolidine compounds except that they are associated with a compound of the general formula xH n Y n- , wherein n is an integer of 1, 2, or 3, x is a number indicating the relative ratio between pyrrole or pyrrolidine and acid (and may be a fraction), and Y is an anion, such as Cl - , Br - , I - , HSO 4 - , SO 4 2- , NO 3 - , HCOO - , CH 3 COO - , HCO 3 - , CO 3 2- , H 2 PO 4 - , HPO 4 2- , PO 4 3- , SCN - , BF 4 - , ClO 4 - , SSO 3 - , CH 3 SO 3 - , CH 3 C 6 H 4 SO 3 - , or the like, as well as mixtures thereof. Examples of pyrrolidine acid salt compounds include (1) 1-amino pyrrolidine hydrochloride (Aldrich 12,310-2), of the formula: (2) 2-(2-chloroethyl)-1-methyl pyrrolidine hydrochloride (Aldrich 13,952-1), of the formula: (3) 1-(2-chloroethyl) pyrrolidine hydrochloride (Aldrich C4,280-7), of the formula: (4) L-proline methyl ester hydrochloride (Aldrich 28,706-7), of the formula: (5) tremorine dihydrochloride (1,1'-(2-butynylene) dipyrrolidine hydrochloride] (Aldrich T4,365-6), of the formula: (6) ammonium pyrrolidine dithiocarbamate (Aldrich 14,269-7), of the formula: (7) pyrrolidone hydrotribromide (Aldrich 15,520-9), of the formula: (8) 1-(4-chlorobenzyl)-2-(1-pyrrolidinyl methyl) benzimidazole hydrochloride (Aldrich 34,208-4), of the formula: (9) billverdin dihydrochloride (Aldrich 25,824-5), of the formula: and the like. Pyridine compounds are those of the general formula wherein R 1 , R 2 , R 3 , R 4 , and R 5 each, independently from one another, can be (but are not limited to) hydrogen, alkyl, substituted alkyl (such as hydroxy alkyl, alkyl sulfonic acid, hydroxy alkyl sulfonic acid, hydroxy alkyl amide, alkyl halide, alkyl imine, alkyl carboxyl, alkyl amine, alkyl imine amide, alkyl phosphate, or the like), carboxyl, amide, carboxyl anhydride, carboxyimide, sulfonic acid, acrylic acid, alkylene, arylalkyl, substituted arylalkyl (such as aryl alkyl amine and the like), hydrazine, hydroxyl, aldehyde, alkoxy, or the like. Other variations are also possible, such as where 2 or more substituents join to form another ring, or the like. Examples of pyridine compounds include (1) 2,3-pyridine dicarboxylic acid (Aldrich P6,320-4), of the formula: (2) 2,4-pyridine dicarboxylic acid monohydrate (Aldrich P6,339-5), of the formula: (3) 2,5-pyridine dicarboxylic acid (Aldrich P6,360-3), of the formula: (4) 2,6-pyridine dicarboxylic acid (Aldrich P6,380-8), of the formula: (5) 3,4-pyridine dicarboxylic acid (Aldrich P6,400-6), of the formula: (6) 3,5-pyridine dicarboxylic acid (Aldrich P6,420-0), of the formula: (7) 2,6-pyridine dicarboxaldehyde (Aldrich 25,600-5), of the formula: (8) 3,4-pyridine carboxamide (Aldrich 32,856-1), of the formula: (9) 3,4-pyridine carboximide (Aldrich 32,858-8), of the formula: (10) 2,3-pyridine carboxylic anhydride (Aldrich P6,440-5), of the formula: (11) 3,4-pyridine carboxylic anhydride (Aldrich 28,271-5), of the formula: (12) 2,6-pyridine methanol (Aldrich 15,436-9), of the formula: (13) 2-pyridine ethane sulfonic acid (Aldrich 30,392-5), of the formula: (14) 4-pyridine ethane sulfonic acid (Aldrich 14,242-5), of the formula: (15) 3-pyridine sulfonic acid (Aldrich P6,480-4), of the formula: (16) pyridoxic acid (Aldrich 28,710-5), of the formula: (17) trans-3-(3-pyridyl) acrylic acid (Aldrich P6,620-3), of the formula: (18) 2-pyridyl hydroxymethane sulfonic acid (Aldrich 85,616-9), of the formula: (19) 3-pyridyl hydroxymethane sulfonic acid (Aldrich P6,840-0), of the formula: (20) 6-methyl-2,3-pyridine dicarboxylic acid (Aldrich 34,418-4), of the formula: (21) isonicotinic acid (Aldrich I-1,750-8), of the formula: (22) N,N-bis (2-hydroxyethyl) isonicotinamide (Aldrich 34,481-8), of the formula: (23) 4,4'-trimethylene pyridine (Aldrich 12,119-3), of the formula: (24) 2-(2-piperidinoethyl) pyridine (Aldrich 30,396-8), of the formula: and the like. The general group of pyridine compounds encompasses pyridine acid salt compounds, which are of the same general formula as pyridine compounds except that they are associated with a compound of the general formula xH n Y n- , wherein n is an integer of 1, 2, or 3, x is a number indicating the relative ratio between pyrrole or pyrrolidine and acid (and may be a fraction), and Y is an anion, such as Cl - , Br - , I - , HSO 4 - , SO 4 2- , NO 3 - , HCOO - , CH 3 COO - , HCO 3 - , CO 3 2- , H 2 PO 4 - , HPO 4 2- , PO 4 3- , SCN - , BF 4 - , ClO 4 - , SSO 3 - , CH 3 SO 3 - , CH 3 C 6 H 4 SO 3 - , or the like, as well as mixtures thereof. Examples of suitable pyridine acid salts include (1) pyridine hydrobromide (Aldrich 30,747-5), of the formula: (2) pyridine hydrochloride (Aldrich 24,308-6), of the formula: (3) 2-(chloromethyl) pyridine hydrochloride (Aldrich 16,270-1), of the formula: (4) 2-pyridylacetic acid hydrochloride (Aldrich P6,560-6), of the formula: (5) nicotinoyl chloride hydrochloride (Aldrich 21,338-1), of the formula: (6) 2-hydrazinopyridine dihydrochloride (Aldrich H1,710-4), of the formula: (7) 2-(2-methyl aminoethyl) pyridine dihydrochloride (Aldrich 15,517-9), of the formula: (8) 1-methyl-1,2,3,6-tetrahydropyridine hydrochloride (Aldrich 33,238-0), of the formula: (9) 2,6-dihydroxypyridine hydrochloride (Aldrich D12,000-6), of the formula: (10) 3-hydroxy-2(hydroxymethyl) pyridine hydrochloride (Aldrich H3,153-0), of the formula: (11) pyridoxine hydrochloride (Aldrich 11,280-1), of the formula: (12) pyridoxal hydrochloride (Aldrich 27,174-8), of the formula: (13) pyridoxal 5-phosphate monohydrate (Aldrich 85,786-6), of the formula: (14) 3-amino-2,6-dimethoxy pyridine hydrochloride (Aldrich 14,325-1), of the formula: (15) pyridoxamine dihydrochloride monohydrate (Aldrich 28,709-1), of the formula: (16) iproniazid phosphate (isonicotinic acid 2-isopropyl hydrazide phosphate) (Aldrich 1-1,265-4), of the formula: (17) tripelennamine hydrochloride (Aldrich 28,738-5), of the formula: and the like. Piperidine compounds are those of the general formula wherein R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 each, independently of one another, can be (but are not limited to) hydrogen, alkyl, substituted alkyl (such as hydroxyalkyl, carboxy alkyl, alkyl nitrile, alkyl imino, and the like), aryl (such as phenyl and the like), substituted aryl, arylalkyl, substituted arylalkyl (such as alkyl phenol and the like), amide, carboxyl, oxo, alkylene, alkoxy, aryloxy, halogenated phenoxy acetate, phosphate, another piperidine moiety, or the like. Other variations are also possible, such as a double bond between one of the ring carbon atoms and another atom, such as carbon, oxygen, or the like. Examples of suitable piperidine compounds include (1) 2-piperidine methanol (Aldrich 15,522-5), of the formula: (2) 3-piperidine methanol (Aldrich 15,523-3), of the formula: (3) 2-piperidine ethanol (Aldrich 13,152-0), of the formula: (4) 4-piperidine ethanol (Aldrich P4,615-6), of the formula: (5) 3-piperidino-1,2-propane diol (Aldrich 21,849-9), of the formula: (6) 1-piperidine propionic acid (Aldrich 33,592-4), of the formula: (7) 2-piperidine carboxylic acid (Alrich 23,775-2, P4,585-0; 26,806-2), of the formula: (8) 4-piperidinopiperidine (Aldrich 15,005-3), of the formula: (9) 4-phenyl piperidine (Aldrich 14,826-1), of the formula: (10) 2,2,6,6-tetramethyl piperidine (Aldrich 11,574-4), of the formula: (11) 2-piperidone (Aldrich V,20-9), of the formula: (12) 1-methyl-4 (methylamino) piperidine (Aldrich 22,140-6), of the formula: (13) 4,4'-trimethylene bis (1-methyl piperidine) (Aldrich 19,226-0), of the formula: (14) 4,4'-trimethylene dipiperidine (Aldrich 12,120-7), of the formula: (15) tris piperidinophosphine oxide (Aldrich 21,625-9), of the formula: (16) 4,4'-trimethylene bis (1-piperidine carboxamide) (Aldrich 34,478-8), of the formula: (17) 4,4'-trimethylene bis (1-piperidine propionitrile) (Aldrich 34,479-6), of the formula: (18) 4-methyl-2-(piperidinomethyl) phenol (Aldrich 34,489-3), of the formula: (19) 1-methyl-4-piperidinyl bis (chlorophenoxy) acetate (Aldrich 21,419-1), of the formula: and the like. Homopiperidine compounds are those of the general formulae wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , and R 15 each, independently of one another, can be (but are not limited to) hydrogen, alkyl, substituted alkyl (such as alkyl imine, alkyl halide, or the like), aryl (such as phenyl or the like), substituted aryl (such as nitropropiophenone or the like), amide, or the like. Other variations are also possible, such as a double bond between one of the ring carbon atoms and another atom, such as carbon, oxygen, or the like, or wherein two or more substituents are joined together to form another ring, or the like. Homopiperidines can also be in acid salt form, wherein they are associated with a compound of the general formula xH n Y n- , wherein n is an integer of 1, 2, or 3, x is a number indicating the relative ratio between pyrrole or pyrrolidine and acid (and may be a fraction), and Y is an anion, such as Cl - , Br - , I - , HSO 4 - , SO 4 2- , NO 3 - , HCOO - , CH 3 COO - , HCO 3 - , CO 3 2- , H 2 PO 4 - , HPO 4 2- , PO 4 3- , SCN - , BF 4 - , ClO 4 - , SSO 3 - , CH 3 SO 3 - , CH 3 C 6 H 4 SO 3 - , or the like, as well as mixtures thereof. Examples of homopiperidine compounds include (1) 2-(hexamethylene imino) ethyl chloride monohydrochloride (Aldrich H 1,065-7), of the formula: (2) 3-(hexahydro-1H-azepin-1-yl)-3'-nitropropiophenone hydrochloride (Aldrich 15,912-3), of the formula: (3) imipramine hydrochloride [5-(3-dimethyl aminopropyl)-10,11-dihydro 5H-dibenz-(b,f) azepine hydrochloride] (Aldrich 28,626-5), of the formula: (4) carbamezepine [5H-dibenzo (b,f)-azepine-5-carboxamide](Adlrich 30,948-6), of the formula: (5) 5,6,11,12-tetrahydro dibenz [b,f] azocine hydrochloride (Aldrich 18,761-5), of the formula: and the like. Quinoline compounds are of the general formula wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 each, independently of one another, can be (but are not limited to) hydrogen, alkyl, substituted alkyl (such as alkyl amide, alkyl halide, alkyl carboxyl, alkyl amino, amido alkyl amine, or the like), aryl (such as phenyl or the like), substituted aryl, hydroxyl, amino, aldehyde, carboxyl, mercapto, alkoxy, amide, or the like. Other variations are also possible, such as wherein one or two of the double bonds in one of the rings is hydrogenated, or wherein two or more substituents are joined together to form a ring, or the like. Examples of suitable quinoline compounds include (1) quinoline (Aldrich Q125-5), of the formula: (2) 2-hydroxyquinoline (Aldrich 27,087-3), of the formula: (3) 4-hydroxy quinoline (Aldrich H5,800-5), of the formula: (4) 5-hydroxy quinoline (Aldrich 12,879-1), of the formula: (5) 8-hydroxy quinoline (Aldrich H5,830-7), of the formula: (6) 3-amino quinoline (Aldrich 23,228-9), of the formula: (7) 5-amino quinoline (Aldrich A7,920-5), of the formula: (8) 6-amino quinoline (Aldrich 27,558-1), of the formula: (9) 8-aminoquinoline (Aldrich 26,078-9), of the formula: (10) 2-quinoline carboxylic acid (Aldrich 16,066-0), of the formula: (11) 3-quinoline carboxylic acid (Aldrich 17,714-8), of the formula: (12) 4-quinoline carboxylic acid (Aldrich 17,482-3), of the formula: (13) 4-quinoline carboxaldehyde (Aldrich 17,696-6), of the formula: (14) 2-quinoline thiol (Aldrich 11,627-0), of the formula: (15) 2,4-quinoline diol (Aldrich Q133-6), of the formula: (16) quinaldine (Aldrich 12,332-3), of the formula: (17) 8-hydroxyquinaldine (Aldrich H5,760-2), of the formula: (18) 4-aminoquinaldine (Aldrich A7,900-0), of the formula: (19) 2,6-dimethyl quinoline (Aldrich 14,402-9), of the formula: (20) 2,7-dimethyl quinoline (Aldrich 14,564-5), of the formula: (21) 4-methoxy-2-quinoline carboxylic acid (Aldrich 30,508-1), of the formula: (22) 7,8-benzoquinoline (Aldrich 12,361-7), of the formula: (23) methyl-2-phenyl-4-quinoline carboxylate (Aldrich 15,367-2), of the formula: (24) 1,2,3,4-tetrahydro quinoline (Aldrich T1,550-4), of the formula: (25) 6-ethoxy-1,2,3,4-tetrahydro-2,2,4-trimethyl quinoline (Aldrich 19,636-3), of the formula: and the like. Isoquinoline compounds are those of the general formula wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 each, independently of one another, can be (but are not limited to) hydrogen, alkyl, substituted alkyl (such as alkyl amide, alkyl halide, alkyl carboxyl, alkyl amino, amido alkyl amine, or the like), aryl (such as phenyl or the like), substituted aryl, hydroxyl, amino, aldehyde, carboxyl, mercapto, alkoxy, amide, or the like. Other variations are also possible, such as wherein one or two of the double bonds in one of the rings is hydrogenated, or wherein two or more substituents are joined together to form a ring, or the like. Examples of suitable isoquinoline compounds include (1) 2-(N-butyl carbamoyl)-1,2,3,4-tetrahydro-isoquinoline (Aldrich 29,156-0), of the formula: (2) 1-hydroxyisoquinoline (Aldrich 15,210-2), of the formula: (3) 1-isoquinoline carboxylic acid (Aldrich 15,013-4), of the formula: (4) 3-isoquinoline carboxylic acid (Aldrich 33,854-0), of the formula: (5) 1,5-isoquinoline diol (Aldrich 28,191-3), of the formula: and the like. The groups of quinoline compounds and isoquinoline compounds encompass quinoline salt compounds and isoquinoline salt compounds, which are of the same general formulae as quinoline and isoquinoline compounds except that they are associated with a compound of the general formula xH n Y n- , wherein n is an integer of 1, 2, or 3, x is a number indicating the relative ratio between pyrrole or pyrrolidine and acid (and may be a fraction), and Y is an anion, such as Cl - , Br - , I - , HSO 4 - , SO 4 2- , NO 3 - , HCOO - , CH 3 COO - , HCO 3 - , CO 3 2- , H 2 PO 4 - , HPO 4 2- , PO 4 3- , SCN - , BF 4 - , ClO 4 - , SSO 3 - , CH 3 SO 3 - , CH 3 C 6 H 4 SO 3 - , or the like, as well as mixtures thereof. Examples of quinoline salt compounds include (1) 8-hydroxyquinoline hemisulfate hemihydrate (Aldrich 10,807-3), of the formula: (2) 5-amino-8-hydroxy quinoline dihydrochloride (Aldrich 30,552-9), of the formula: (3) 2-(chloromethyl) quinoline monohydrochloride (Aldrich C5,710-3), of the formula: (4) 8-hydroxyquinoline-5-sulfonic acid monohydrate (Aldrich H5,875-7), of the formula: (5) 8-ethoxy-5-quinoline sulfonic acid sodium salt hydrate (Aldrich 17,346-0), of the formula: (6) 1,2,3,4-tetrahydroisoquinoline hydrochloride (Aldrich 30,754-8), of the formula: (7) 1,2,3,4-tetrahydro-3-isoquinoline carboxylic acid hydrochloride (Aldrich 21,493-0), of the formula: (8) 6,7-dimethoxy-1,2,3,4-tetrahydro isoquinoline hydrochloride (Aldrich 29,191-9), of the formula: (9) 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydro isoquinoline hydrobromide (Aldrich 24,420-1), of the formula: (10) primaquine diphosphate [8-(4-amino-1-methyl butyl amino)-6-methoxy quinoline diphosphate] (Aldrich 16,039-3), of the formula: (11) pentaquine phosphate (Aldrich 30,207-4), of the formula: (12) dibucaine hydrochloride [2-butoxy-N-(2-diethyl amino ethyl)-4-quinoline carboxamide hydrochloride] (Aldrich 28,555-2), of the formula: (13) 9-aminoacridine hydrochloride hemihydrate (Aldrich A3,840-1), of the formula: (14) 3, 6-diamino acridine hemisulfate (Aldrich 19,822-6), of the formula: (15) 2-quinoline thiol hydrochloride (Aldrich 35,978-5),of the formula: (16) (-) sparteine sulfate pentahydrate (Aldrich 23,466-4), of the formula: (17) papaverine hydrochloride (Aldrich 22,287-9), of the formula: (18) (+)-emetine dihydrochloride hydrate (Aldrich 21,928-2), of the formula: (19) 1,10-phenanthroline monohydrochloride monohydrate (Aldrich P1,300-2), of the formula: (20) neocuproine hydrochloride trihydrate (Aldrich 12,189-6), of the formula: and the like. Quinuclidine compounds are those of the general formula wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 each, independently of one another, can be (but are not limited to) hydrogen, alkyl, substituted alkyl (such as alkyl hydroxyl, quinoline alkyl alcohol, or the like), hydroxyl, oxo, amino, vinyl, halide, or the like, and wherein n is an integer of 1, 2, or 3, x is a number indicating the relative ratio between pyrrole or pyrrolidine and acid (and may be a fraction), and Y is an anion, such as Cl - , Br - , I - , HSO 4 - , SO 4 2- , NO 3 - , HCOO - , CH 3 COO - , HCO 3 - , CO 3 2- , H 2 PO 4 - , HPO 4 2- , PO 4 3- , SCN - , BF 4 - , ClO 4 - , SSO 3 - , CH 3 SO 3 - , CH 3 C 6 H 4 SO 3 - , or the like, as well as mixtures thereof. Other variations, however, are possible, such as when one of the carbon atoms forming the rings of the basic quinuclidine system is connected to another atom, such as carbon or oxygen, by a double bond. Examples of suitable quinuclidine compounds include (1) quinuclidine hydrochloride (Aldrich 13,591-7), of the formula: (2) 3-quinuclidinol hydrochloride (Aldrich Q188-3), of the formula: (3) 3-quinuclidinone hydrochloride (Aldrich Q190-5), of the formula: (4) 2-methylene-3-quinuclidinone dihydrate hydrochloride (Aldrich M4,612-8), of the formula: (5) 3-amino quinuclidine dihydrochloride (Aldrich 10,035-8), of the formula: (6) 3-chloro quinuclidine hydrochloride (Aldrich 12,521-0), of the formula: (7) quinidine sulfate dihydrate (Aldrich 14,589-0), of the formula: (8) quinine monohydrochloride dihydrate (Aldrich 14,592-0), of the formula: (9) quinine sulfate monohydrate (Aldrich 14,591-2), of the formula: (10) hydroquinidine hydrochloride (Aldrich 25,481-9), of the formula: (11) hydroquinine hydrobromide dihydrate (Aldrich 34,132-0), of the formula: and the like. Indole compounds are those of the general formula wherein R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 each, independently of one another, can be (but are not limited to) hydrogen, alkyl, substituted alkyl (such as alkyl hydroxyl, alkyl amide, alkyl carboxyl, alkyl carbonyl carboxyl, alkyl hydroxy carboxyl, acetamido alkyl carboxyl, alkyl phenyl carboxyl, or the like), aryl, substituted aryl, arylalkyl, substituted arylalkyl (such as alkyl phenyl carboxyl or the like), alkoxy, aldehyde, hydroxyl, acetate, carboxyl, acrylic carboxyl, carbonyl carboxyl, dione, and the like. Other variations are also possible, such as wherein one or more of the double bonds in either the five-membered ring or the six-membered ring are saturated, and/or wherein one or more of the ring carbon atoms is attached to another atom, such as carbon, oxygen, sulfur, or the like by a double bond, or the like. Examples of suitable indole compounds include (1) indole (Aldrich 1-340-8), of the formula: (2) 4,5,6,7-tetrahydroindole (Aldrich 32,490-6), of the formula: (3) 3-indolemethanol hydrate (Aldrich 1-400-5), of the formula: (4) 3-indole ethanol (tryptophol) (Aldrich T9,030-1), of the formula: (5) indole-3-carboxaldehyde (Aldrich 12,944-5), of the formula: (6) 3-indolylacetate (3-acetoxyindole) (Aldrich 25,946-1), of the formula: (7) indole-3-acetamide (Aldrich 28,628-1), of the formula: (8) indole-3-carboxylic acid (Aldrich 28,473-4), of the formula: (9) indole-3-acetic acid (Aldrich 1-375-0), of the formula: (10) 3-indole propionic acid (Aldrich 22,002-7), of the formula: (11) 3-indole acrylic acid (Aldrich 1-380-7), of the formula: (12) 3-indole glyoxylic acid (Aldrich 22,001-9), of the formula: (13) indole-3-pyruvic acid (Aldrich 1-556-7), of the formula: (14) D,L-3-indolelactic acid (Aldrich 1-550-8), of the formula: (15) 3-indole butyric acid (Aldrich 13,915-7), of the formula: (16) N-acetyl-L-tryptophanamide (Aldrich 85,675-4), of the formula: (17) N-(3-indolylacetyl)-L-alanine (Aldrich 34,591-1), of the formula: (18) N-(3-indolyl acetyl)-L-valine (Aldrich 34,792-2), of the formula: (19) N-(3-indolyl acetyl)-L-isoleucine (Aldrich 34,791-4), of the formula: (20) N-(3-indolyl acetyl)-L-leucine (Aldrich 34,594-6), of the formula: (21) N-(3-indolyl acetyl)-D,L-aspartic acid (Aldrich 34,593-8), of the formula: (22) N-(3-indolyl acetyl)-L-phenylalanine (Aldrich 34,595-4), of the formula: (23) 4-hydroxyindole (4-indolol) (Aldrich 21,987-8), of the formula: (24) indole-4-carboxylic acid (Aldrich 24,626-3), of the formula: (25) 4-indolyl acetate (Aldrich 25,904-7), of the formula: (26) 4-methylindole (Aldrich 24,630-1), of the formula: (27) 5-hydroxy indole (5-indolol) (Aldrich H3,185-9), of the formula: (28) 5-hydroxy indole-3-acetic acid (Aldrich H3,200-6), of the formula: (29) 5-hydroxy-2-indole carboxylic acid (Aldrich 14,351-0), of the formula: (30) N-acetyl-5-hydroxytryptamine (Aldrich 85,548-0), of the formula: (31) indole-5-carboxylic acid (Aldrich 1-540-0), of the formula: (32) 5-methyl indole (Aldrich 22,241-0), of the formula: (33) 5-methoxy indole (Aldrich M,1490-0), of the formula: (34) indole-2-carboxylic acid (Aldrich 1-510-9), of the formula: (35) D,L-indolene-2-carboxylic acid (Aldrich 30,224-4), of the formula: (36) indole-2,3-dione (isatin) (Aldrich 11,461-8), of the formula: (37) 2-methyl indole (Aldrich M5, 140-7), of the formula: (38) 2,3,3-trimethyl indolenine (Aldrich T7,680-5), of the formula: and the like. Indazole compounds are of the general formula wherein R 1 , R 2 , R 3 , R 4 , and R 5 each, independently of one another, can be (but are not limited to) hydrogen, alkyl, substituted alkyl (such as alkyl amine, or the like), aryl (such as phenyl or the like), substituted aryl (such as phenyl hydrazine or the like), amino, oxo, sulfanilamide, pyridinyl, hydroxyl, alkoxy, hydrazine, isothiouronium, isoquinoline, substituted isoquinoline, and the like. Other variations are also possible, such as wherein one or more of the double bonds in either the five-membered ring or the six-membered ring is saturated, or wherein two or more substituents are joined to form another ring, or the like. Examples of indazole compounds include (1) indazole (Aldrich 1,240-1), of the formula: (2) 5-aminoindazole (Aldrich A5,955-7), of the formula: (3) 6-aminoindazole (Aldrich A5,956-5), of the formula: (4) 3-indazolinone (Aldrich 1260-6), of the formula: (5) N'-(6-indazolyl) sulfanilamide (Aldrich 15,530-6), of the formula: (6) 4,5-dihydro-3-(4-pyridinyl)-2H-benz[g] indazole methane sulfonate (Aldrich 21,413-2), of the formula: and the like. The general group of indole compounds encompasses indole salts, which are of the same general formula as indole compounds except that they are associated with compounds of the formula xH n Y n- , wherein n is an integer of 1, 2, or 3, x is a number indicating the relative ratio between pyrrole or pyrrolidine and acid (and may be a fraction), and Y is an anion, such as Cl - , Br - , I - , HSO 4 - , SO 4 2- , NO 3 - , HCOO - , CH 3 COO - , HCO 3 - , CO 3 2- , H 2 PO 4 - , HPO 4 2- , PO 4 3- , SCN - , BF 4 - , ClO 4 - , SSO 3 - , CH 3 SO 3 - , CH 3 C 6 H 4 SO 3 - , or the like, as well as mixtures thereof. Examples of indole salts include (1) tryptamine hydrochloride (Aldrich 13,224-1), of the formula: (2) 5-methyl tryptamine hydrochloride (Aldrich 13,422-8), of the formula: (3) serotonin hydrochloride hemihydrate (5-hydroxy tryptamine hydrochloride hemihydrate) (Aldrich 23,390-0), of the formula: (4) norharman hydrochloride monohydrate (Aldrich 28,687-7), of the formula: (5) harmane hydrochloride monohydrate (Aldrich 25,051-1), of the formula: (6) harmine hydrochloride hydrate (Aldrich 12,848-1), of the formula: (7) harmaline hydrochloride dihydrate (Aldrich H10-9), of the formula: (8) harmol hydrochloride dihydrate (Aldrich 11,655-6), of the formula: (9) harmalol hydrochloride dihydrate (Aldrich H12-5), of the formula: (10) 3,6-diamino acridine hydrochloride (Aldrich 13,110-5), of the formula: (11) S-(3-indolyl) isothiuronium iodide (Aldrich 16,097-0), of the formula: (12) yohimbine hydrochloride (Aldrich Y20-8), of the formula: (13) 4,5-dihydro-3-(4-pyridinyl)-2H-benz[g] indazole methane sulfonate (Aldrich 21,413-2), of the formula: and the like. Mixtures of any two or more of the above materials can also be employed. The pyrrole compound, pyrrolidine compound, pyridine compound, piperidine compound, homopiperidine compound, quinoline compound, isoquinoline compound, quinuclidine compound, indole compound, indazole compound, or mixture thereof is present in any effective amount relative to the substrate. Typically, the pyrrole compound, pyrrolidine compound, pyridine compound, piperidine compound, homopiperidine compound, quinoline compound, isoquinoline compound, quinuclidine compound, indole compound, indazole compound, or mixture thereof is present in an amount of from about 1 to about 50 percent by weight of the substrate, preferably from about S to about 30 percent by weight of the substrate, although the amount can be outside this range. The amount can also be expressed in terms of the weight of pyrrole compound, pyrrolidine compound, pyridine compound, piperidine compound, homopiperidine compound, quinoline compound, isoquinoline compound, quinuclidine compound, indole compound, indazole compound, or mixture thereof per unit area of substrate. Typically, the pyrrole compound, pyrrolidine compound, pyridine compound, piperidine compound, homopiperidine compound, quinoline compound, isoquinoline compound, quinuclidine compound, indole compound, indazole compound, or mixture thereof is present in an amount of from about 0.8 to about 40 g per square meter of the substrate surface to which it is applied, and preferably from about 4 to about 24 g per square meter of the substrate surface to which it is applied, although the amount can be outside these ranges. When the pyrrole compound, pyrrolidine compound, pyridine compound, piperidine compound, homopiperidine compound, quinoline compound, isoquinoline compound, quinuclidine compound, indole compound, indazole compound, or mixture thereof is applied to the substrate as a coating, the coatings employed for the recording sheets of the present invention can include an optional binder in addition to the pyrrole compound, pyrrolidine compound, pyridine compound, piperidine compound, homopiperidine compound, quinoline compound, isoquinoline compound, quinuclidine compound, indole compound, indazole compound, or mixture thereof. Examples of suitable binder polymers include (a) hydrophilic polysaccharides and their modifications, (b) vinyl polymers, (c) formaldehyde resins, (d) ionic polymers, (e) latex polymers, (f) maleic anhydride and maleic acid containing polymers, (g) acrylamide, and (h) poly(alkyleneimine) containing polymers, wherein alkylene has two (ethylene), three (propylene), or four (butylene) carbon atoms, and the like, as well as blends or mixtures of any of the above, with starches and latexes being particularly preferred because of their availability and applicability to paper. Specific examples of suitable binders are mentioned in U.S. application S.N. 08/196,676 (a divisional application thereof has issued as US-Patent 5,657,064). Any mixtures of the above ingredients in any relative amounts can be employed. If present, the binder can be present within the coating in any effective amount; typically the binder and the pyrrole compound, pyrrolidine compound, pyridine compound, piperidine compound, homopiperidine compound, quinoline compound, isoquinoline compound, quinuclidine compound, indole compound, indazole compound, or mixture thereof are present in relative amounts of from about 10 percent by weight binder and about 90 percent by weight pyrrole compound, pyrrolidine compound, pyridine compound, piperidine compound, homopiperidine compound, quinoline compound, isoquinoline compound, quinuclidine compound, indole compound, indazole compound, or mixture thereof to about 99 percent by weight binder and about 1 percent by weight pyrrole compound, pyrrolidine compound, pyridine compound, piperidine compound, homopiperidine compound, quinoline compound, isoquinoline compound, quinuclidine compound, indole compound, indazole compound, or mixture thereof, although the relative amounts can be outside of this range. In addition, the coating of the recording sheets of the present invention can contain optional antistatic agents. Any suitable or desired antistatic agent or agents can be employed, such as quaternary salts and other materials as disclosed in, for example, copending applications 08/034,917, 08/034,943, 08/033,917, 08/034,445, and 08,033,918 (US-Patents 5,760,809; 5,314,747; 5,441,795; 5,320,902 and 5,457,486, respectively), the disclosures of each of which are totally incorporated herein by reference. The antistatic agent can be present in any effective amount; typically, the antistatic agent is present in an amount of from about 1 to about 5 percent by weight of the coating, and preferably in an amount of from about 1 to about 2 percent by weight of the coating, although the amount can be outside these ranges. Further, the coating of the recording sheets of the present invention can contain one or more optional biocides. Examples of suitable biocides include (A) non-ionic biocides, (B) an ionic biocides, (C) cationic biocides, and the like, as well as mixtures thereof. Specific examples of suitable biocides are mentioned in U.S. application S.N. 08/196,676 (a divisional application thereof has issued as US-Patent 5,657,064). The biocide can be present in any effective amount; typically, the biocide is present in an amount of from about 10 parts per million to about 3 percent by weight of the coating, although the amount can be outside this range. Additionally, the coating of the recording sheets of the present invention can contain optional filler components. Fillers can be present in any effective amount, and if present, typically are present in amounts of from about 1 to about 60 percent by weight of the coating composition. Examples of filler components include colloidal silicas, such as Syloid 74®, available from Grace Company (preferably present, in one embodiment, in an amount of about 20 weight percent). Other suitable filler components are mentioned in U.S. application S.N. 08/196,676 (a divisional application thereof has issued as US-Patent 5,657,064). The coating containing the pyrrole compound, pyrrolidine compound, pyridine compound, piperidine compound, homopiperidine compound, quinoline compound, isoquinoline compound, quinuclidine compound, indole compound, indazole compound, or mixture thereof is present on the substrate of the recording sheet of the present invention in any effective thickness. Typically, the total thickness of the coating layer (on each side, when both surfaces of the substrate are coated) is from about 1 to about 25 µm and preferably from about 5 to about 10 µm, although the thickness can be outside of these ranges. The pyrrole compound, pyrrolidine compound, pyridine compound, piperidine compound, homopiperidine compound, quinoline compound, isoquinoline compound, quinuclidine compound, indole compound, indazole compound, or mixture thereof or the mixture of pyrrole compound, pyrrolidine compound, pyridine compound, piperidine compound, homopiperidine compound, quinoline compound, isoquinoline compound, quinuclidine compound, indole compound, indazole compound, or mixture thereof, optional binder, optional antistatic agent, optional biocide, and/or optional filler can be applied to the substrate by any suitable technique, such as size press treatment, dip coating, reverse roll coating, extrusion coating, or the like. For example, the coating can be applied with a KRK® size press (Kumagai Riki Kogyo Co., Ltd., Nerima, Tokyo, Japan) by dip coating and can be applied by solvent extrusion on a Faustel Coater. The KRK® size press is a lab size press that simulates a commercial size press. This size press is normally sheet fed, whereas a commercial size press typically employs a continuous web. On the KRK® size press, the substrate sheet is taped by one end to the carrier mechanism plate. The speed of the test and the roll pressures are set, and the coating solution is poured into the solution tank. A 4 liter stainless steel beaker is situated underneath for retaining the solution overflow. The coating solution is cycled once through the system (without moving the substrate sheet) to wet the surface of the rolls and then returned to the feed tank, where it is cycled a second time. While the rolls are being "wetted", the sheet is fed through the sizing rolls by pressing the carrier mechanism start button. The coated sheet is then removed from the carrier mechanism plate and is placed on at (12 inch by 40 inch) 30x100cm sheet of 750 µm thick Teflon® for support and is dried on the Dynamic Former® drying drum and held under restraint to prevent shrinkage. The drying temperature is approximately 105°C. This method of coating treats both sides of the substrate simultaneously. In dip coating, a web of the material to be coated is transported below the surface of the liquid coating composition by a single roll in such a manner that the exposed site is saturated, followed by removal of any excess coating by the squeeze rolls and drying at 100°C in an air dryer. The liquid coating composition generally comprises the desired coating composition dissolved in a solvent such as water, methanol, or the like. The method of surface treating the substrate using a coater results in a continuous sheet of substrate with the coating material applied first to one side and then to the second side of this substrate. The substrate can also be coated by a slot extrusion process, wherein a flat die is situated with the die lips in close proximity to the web of substrate to be coated, resulting in a continuous film of the coating solution evenly distributed across one surface of the sheet, followed by drying in an air dryer at 100°C. Recording sheets of the present invention can be employed in ink jet printing processes. One embodiment of the present invention is directed to a process which comprises applying an aqueous recording liquid to a recording sheet of the present invention in an imagewise pattern. Another embodiment of the present invention is directed to a printing process which comprises (1) incorporating into an ink jet printing apparatus containing an aqueous ink a recording sheet of the present invention, and (2) causing droplets of the ink to be ejected in an imagewise pattern onto the recording sheet, thereby generating images on the recording sheet. Ink jet printing processes are well known, and are described in, for example, US-A-4,601,777, US-A-4,251,824, US-A-4,410,899, US-A4,412,224, and US-A-4,532,530. In a particularly preferred embodiment, the printing apparatus employs a thermal ink jet process wherein the ink in the nozzles is selectively heated in an imagewise pattern, thereby causing droplets of the ink to be ejected in imagewise pattern. In another preferred embodiment, the substrate is printed with an aqueous ink and thereafter the printed substrate is exposed to microwave radiation, thereby drying the ink on the sheet. Printing processes of this nature are disclosed in, for example, U.S. Patent 5,220,346, the disclosure of which is totally incorporated herein by reference. The recording sheets of the present invention can also be used in any other printing or imaging process, such as printing with pen plotters, handwriting with ink pens, offset printing processes, or the like, provided that the ink employed to form the image is compatible with the ink receiving layer of the recording sheet. Recording sheets of the present invention exhibit reduced curl upon being printed with aqueous inks, particularly in situations wherein the ink image is dried by exposure to microwave radiation. Generally, the term "curl" refers to the distance between the base line of the arc formed by recording sheet when viewed in cross-section across its width (or shorter dimension - for example, (8.5 inches) 21.6cm in an (8.5 × 11 inch) 21.6x27.9cm sheet, as opposed to length, or longer dimension - for example, (11 inches) 27.9cm in an (8.5× 11 inch) 21.6x27.9cm sheet) and the midpoint of the arc. To measure curl, a sheet can be held with the thumb and forefinger in the middle of one of the long edges of the sheet (for example, in the middle of one of theft (11 inch) 27.9cm edges in an (8.5 × 11 inch) 21.6x27.9cm sheet) and the arc formed by the sheet can be matched against a pre-drawn standard template curve. Specific embodiments of the invention will now be described in detail. These examples are intended to be illustrative, and the invention is not limited to the materials, conditions, or process parameters set forth in these embodiments. All parts and percentages are by weight unless otherwise indicated. The optical density measurements recited herein were obtained on a Pacific Spectrograph Color System®. The system consists of two major components, an optical sensor and a data terminal. The optical sensor employs a 15.3 cm (6 inch) integrating sphere to provide diffuse illumination and 8 degrees viewing. This sensor can be used to measure both transmission and reflectance samples. When reflectance samples are measured, a specular component may be included. A high resolution, full dispersion, grating monochromator was used to scan the spectrum from 380 to 720 nanometers. The data terminal features a 30.5 cm (12 inch) CRT display, numerical keyboard for selection of operating parameters and the entry of tristimulus values, and an alphanumeric keyboard for entry of product standard information. EXAMPLE I Transparency sheets were prepared as follows. Blends of 70 percent by weight hydroxypropyl methyl cellulose (K35LV®, obtained from Dow Chemical Co.) and 30 percent by weight of various additive compositions, each obtained from Aldrich Chemical Co., were prepared by mixing 56 g of hydroxypropyl methyl cellulose and 24 g of the additive composition in 1,000 milliliters of water in a 2 Liter jar and stirring the contents in an Omni® homogenizer for 2 hours. Subsequently, the solution was left overnight for removal of air bubbles. The blends thus prepared were then coated by a dip coating process (both sides coated in one operation) by providing Mylar® base sheets in cut sheet form ((8.5 × 11 inches) 21.6x27.9cm) in a tnickness of 100 µm. Subsequent to air drying at 25°C for 3 hours followed by oven drying at 100°C for 10 minutes and monitoring the difference in weight prior to and subsequent to coating, the dried coated sheets were each coated with 1 g, 10 µm in thickness, on each surface (2 g total coating weight for 2-sided transparency) of the substrate. For comparison purposes, a transparency sheet was also prepared in which the coating consisted of 100 percent by weight hydroxypropyl methyl cellulose and contained no additive composition. The transparency sheets thus prepared were incorporated into a Hewlett-Packard 500-C® color ink jet printer containing inks of the following compositions: Cyan: 20 percent by weight ethylene glycol, 2.5 percent by weight benzyl alcohol, 1.9 percent by weight ammonium chloride, 0.1 percent by weight Dowicil 150 biocide, obtained from Dow Chemical Co., Midland, Ml, 0.05 percent by weight polyethylene oxide (molecular weight 18,500), obtained from Union Carbide Co.), 30 percent by weight Projet Cyan 1 dye, obtained from ICI, 45.45 percent by weight water. Magenta: 20 percent by weight ethylene glycol, 2.5 percent by weight benzyl alcohol, 1.9 percent by weight ammonium chloride, 0.1 percent by weight Dowicil 150® biocide, obtained from Dow Chemical Co., Midland, MI, 0.05 percent by weight polyethylene oxide (molecular weight 18,500), obtained from Union Carbide Co.), 2.5 percent by weight Triton Direct Red 227, obtained from Tricon, 72.95 percent by weight water Yellow: 20 percent by weight ethylene glycol, 2.5 percent by weight benzyl alcohol, 1.9 percent by weight ammonium chloride, 0.1 percent by weight Dowicil 150® biocide, obtained from Dow Chemical Co., Midland, Ml, 0.05 percent by weight polyethylene oxide (molecular weight 18,500), obtained from Union Carbide Co.), 3 percent by weight Hoechst Duasyn Brilliant Yellow SF-GL VP220, obtained from Hoechst, 72.45 percent by weight water. Images were generated by printing block patterns for magenta, cyan, yellow, and black. The images thus formed were dried by exposure to microwave radiation with a Citizen Model No. JM55581®, obtained from Consumers, Mississauga, Ontario, Canada, set at 700 Watts output power at 2450 MHz frequency. The black images were "process black" (i.e., formed by superimposition of cyan, magenta, and yellow images). The drying times and optical densities for the resulting images were as follows: Additive Drying Time (seconds) Optical Density black cyan magenta yellow black cyan magenta yellow none 30 20 30 20 2.50 2.07 1.45 0.99 1-benzyl-3-piperidone hydrochloride hydrate 20 40 10 20 1.85 1.68 1.50 0.95 2-(2-methylamino ethyl) pyridine dihydrochloride 20 15 25 15 1.85 2.10 1.52 0.97 D,L-pipecolinic acid hydrochloride 10 30 30 20 1.87 1.90 1.53 0.98 8-ethoxy-5-quinoline sulfonic acid sodium salt 10 20 20 20 1.75 1.70 1.30 0.90 As the results indicate, the drying times of all colors were equivalent or faster in the presence of the additives than in their absence. In addition, the optical densities of the images were also acceptable and in some instances were improved. EXAMPLE II Transparency sheets were prepared as follows. Blends of 54 percent by weight hydroxypropyl methyl cellulose (K35LV®, obtained from Dow Chemical Co.), 36 percent by weight poly(ethylene oxide) (POLY OX WSRN-3000®, obtained from Union Carbide Corp., and 10 percent by weight of various additive compositions, each obtained from Aldrich Chemical Co., were prepared by mixing 43.2 g of hydroxypropyl methyl cellulose, 28.8 g of poly(ethylene oxide), and 8 g of the additive composition in 1,000 milliliters of water in a 2 Liter jar and stirring the contents in an Omni homogenizer for 2 hours. Subsequently, the solution was left overnight for removal of air bubbles. The blends thus prepared were then coated by a dip coating process (both sides coated in one operation) by providing Mylar® base sheets in cut sheet form ((8.5 × 11 inches) 21.6x27.9cm in a thickness of 100 µm. Subsequent to air drying at 25°C for 3 hours followed by oven drying at 100°C for 10 minutes and monitoring the difference in weight prior to and subsequent to coating, the dried coated sheets were each coated with 1 g, 10 µm in thickness, on each surface (2 g total coating weight for 2-sided transparency) of the substrate. For comparison purposes, a transparency sheet was also prepared in which the coating consisted of 60 percent by weight hydroxypropyl methyl cellulose and 40 percent by weight poly(ethylene oxide) and contained no additive composition. The transparency sheets thus prepared were incorporated into a Hewlett-Packard 500-C® color ink jet printer containing inks of the following compositions: Cyan: Same as Example I. Magenta : Same as Example I. Yellow: Same as Example I. Images were generated by printing block patterns for magenta, cyan, yellow, and black. The images thus formed were allowed to dry at 25°C. The black images were "process black" (i.e., formed by superimposition of cyan, magenta, and yellow images). The drying times and optical densities for the resulting images were as follows: Additive Drying Time (minutes) Optical Density black cyan magenta yellow black cyan magenta yellow none 15 10 10 10 1.40 1.46 1.34 1.02 1-aminopyrrolidine hydrochloride 10 6 5 5 1.44 1.38 1.28 0.93 L-proline methyl ester hydrochloride 8 5 5 5 1.42 1.40 1.23 0.95 4,4'-bipiperidine hydrochloride 7 4 4 4 1.38 1.40 1.26 0.93 pyridoxine hydrochloride 7 5 4 4 1.40 1.38 1.02 0.84 As the results indicate, the drying times of the transparencies containing the additives were generally faster than the drying times of the transparency containing no additives. In addition, the optical densities of the images on the transparencies containing the additives were acceptable in all instances. EXAMPLE III Transparency sheets were prepared as follows. Blends of 90 percent by weight hydroxypropyl methyl cellulose (K3SLV®, obtained from Dow Chemical Co.) and 10 percent by weight of various additive compositions, each obtained from Aldrich Chemical Co., were prepared by mixing 72 g of hydroxypropyl methyl cellulose and 8 g of the additive composition in 1,000 milliliters of water in a 2 Liter jar and stirring the contents in an Omni homogenizer for 2 hours. Subsequently, the solution was left overnight for removal of air bubbles. The blends thus prepared were then coated by a dip coating process (both sides coated in one operation) by providing Mylar® base sheets in cut sheet form ((8,5 × 11 inches) 21.6x27.9cm) in a thickness of 100 µm. Subsequent to air drying at 25°C for 3 hours followed by oven drying at 100°C for 10 minutes and monitoring the difference in weight prior to and subsequent to coating, the dried coated sheets were each coated with 1 g, 10 µm in thickness, on each surface (2 g total coating weight for 2-sided transparency) of the substrate. For comparison purposes, a transparency sheet was also prepared in which the coating consisted of 100 percent by weight hydroxypropyl methyl cellulose and contained no additive composition. The transparency sheets thus prepared were incorporated into a Hewlett-Packard 500-C® color ink jet printer containing inks of the following compositions: Cyan: Same as Example I Magenta: Same as Example I. Yellow: Same as Example I. Images were generated by printing block patterns for magenta, cyan, yellow, and black. The images thus formed were allowed to dry at 25°C. The black images were "process black" (i.e., formed by superimposition of cyan, magenta, and yellow images). The drying times and optical densities for the resulting images were as follows: Additive Drying Time (minutes) Optical Density black cyan magenta yellow black cyan magenta yellow none 10 5 5 2 2.95 2.10 1.37 0.99 1-benzyl-3-piperidone hydrochloride hydrate 6 3 3 2 2.90 2.12 1.40 0.95 2-iminopiperidine hydrochloride 6 3 3 2 1.60 1.80 1.40 0.95 2-(2-methylamino ethyl)pyridine dihydrochloride 7 3 5 1 1.50 2.20 1.53 0.92 D,L-pipecolinic acid hydrochloride 5 1.5 3 1 1.68 2.05 1.50 0.90 8-ethoxy-5-quinoline sulfonic acid sodium salt 8 4 4 1.5 1.70 1.85 1.38 0.86 3-quinuclidinol hydrochloride 6 3 3 2 1.50 1.93 1.51 0.97 3-quinuclidinone hydrochloride 6 3 3 2 2.10 1.65 1.35 0.78 3-chloroquinuclidine hydrochloride 7 3 5 1.5 1.86 1.98 1.35 0.84 3-amino quinuclidine dihydrochloride 7 2.5 5 1.5 1.60 1.68 1.40 0.80 4-amino quinaldine (methanol) 5 2 2 1.5 1.74 1.45 1.66 0.96 8-hydroxyquinaldine (methanol) 5 2 2 1.5 1.60 1.95 1.30 0.97 As the results indicate, the drying times of the transparencies containing the additives were generally faster than the drying times of the transparency containing no additives. In addition, the optical densities of the images on the transparencies containing the additives were acceptable and in some instances improved compared to those on the transparencies containing no additives. EXAMPLE IV Paper recording sheets were prepared as follows. Coating compositions containing various additive compositions, each obtained from Aldrich Chemical Co., were prepared by dissolving 50 g of the additive in 500 milliliters of water in a beaker and stirring for 1 hour at 25°C. The additive solutions thus prepared were then coated onto paper by a dip coating process (both sides coated in one operation) by providing paper base sheets in cut sheet form ((8.5 × 11 inches) 21.6x27.9cm)) in a thickness of 100 µm. Subsequent to air drying at 100°C for 10 minutes and monitoring the difference in weight prior to and subsequent to coating, the sheets were each coated on each side with 500 mg in a thickness of 5 µm (total coating weight 1 g for two-sided sheets), of the additive composition For comparison purposes, an uncoated paper sheet treated with a composition containing only water by the same procedure was also imaged. The paper sheets thus prepared were incorporated into a Hewlett-Packard 500-C® color ink jet printer containing inks of the following composition: Cyan: Same as Example I. Magenta: Same as Example I. Yellow: Same as Example I. Images were generated with 100 percent ink coverage. After the image was printed, the paper sheets were each weighed precisely in a precision balance at time zero and periodically after that. The difference in weight was recorded as a function of time, 100 minutes being considered as the maximum time required for most of the volatile ink components to evaporate. (Volatiles were considered to be ink components such as water and glycols that can evaporate, as compared to components such as dyes, salts, and/or other non-volatile components. Knowing the weight of ink deposited at time zero, the amount of volatiles in the image can be calculated.) After 1000 minutes, the curl values of thepaper were measured and are listed in the Table below. The black images were "process black" (i.e., formed by superimposition of cyan, magenta, and yellow images). Additive Percent weight-loss of volatiles at various times (minutes) 1,000 minutes 5 10 15 30 60 120 wt. loss % curl in mm none 32 43 45 48 50 53 65 125 2-pyrrolidone-5-carboxylic acid 34 46 50 55 58 60 73 30 1-aminopyrrolidine hydrochloride 32 47 51 57 61 65 85 30 L-proline methyl ester hydrochloride 37 52 58 65 68 72 88 30 1-(4-chlorobenzy)-2-(1-pyrrolidinyl methyl) benzimidazole hydrochloride 40 54 59 62 66 72 91 20 2-piperidine methanol 36 51 57 63 66 69 99 25 2-piperidine carboxylic acid hydrochloride 32 43 46 49 55 61 80 45 1-benzyl-3-piperidone hydrochloride hydrate 31 37 40 45 52 58 81 45 2-iminopiperidine hydrochloride 36 46 47 49 54 66 85 15 4,4'-bipiperidine dihydrochloride 35 50 53 58 63 66 75 30 5,6,11,12-tetra hydrodibenz [b,f] azocine hydrochloride 34 50 53 55 58 62 80 20 2-(2-piperidino ethyl) pyridine 24 32 37 40 50 60 75 25 2-(2-methylamino ethyl) pyridine dihydrochloride 33 45 49 52 54 56 75 10 pyridoxamine dihydrochloride monohydrate 36 52 57 62 65 68 91 10 indole-2-carboxylic acid 34 46 51 55 61 66 100 5 indazole 33 47 51 56 60 66 100 5 Additive Percent weight-loss of volatiles at various times (minutes) 1,000 minutes 5 10 15 30 60 120 wt loss % curl in mm tryptamine hydrochloride 33 47 51 58 63 70 87 10 harmane hydrochloride monohydrate (in methanol) 33 48 53 58 60 65 81 15 4-hydroxyquinoline 46 56 59 62 65 70 80 35 1,5-isoquinolinediol 42 57 60 62 65 70 80 25 1-isoquinoline carboxylic acid 39 50 54 60 62 75 86 50 8-hydroxyquinaldine 42 55 59 64 69 73 100 30 4-aminoquinaldine 19 33 39 43 46 50 76 50 1,2,3,4-tetrahydro isoquinoline hydrochloride 31 45 49 52 55 60 91 10 1,2,3,4-tetrahydro-3-isoquinoline carboxylic acid hydrochloride 36 47 50 55 59 65 70 20 2-(chloromethyl) quinoline monohydrochloride 31 47 54 59 63 65 74 5 8-ethoxy-5-quinoline sulfonic acid, sodium salt hydrate 36 47 49 52 55 60 85 20 3-chloroquinuclidine hydrochloride 32 46 50 56 68 71 100 0 3-aminoquinuclidine dihydrochloride 26 41 48 54 65 72 100 0 3-quinuclidinol hydrochloride 35 49 53 58 60 62 75 45 3-quinuclidinone hydrochloride 39 49 54 56 60 65 78 35 neocuproine hydrochloride trihydrate 35 48 52 57 58 63 91 55 As the results indicate, the papers coated with the additives exhibited higher weight loss of volatiles at time 1,000 minutes compared to the paper which had been treated with water alone. In addition, the papers coated with the additives exhibited lower curl values compared to the curl value for the paper treated with water alone. EXAMPLE V Paper recording sheets were prepared as follows. Coating compositions containing various additive compositions, each obtained from Aldrich Chemical Co., were prepared by dissolving 50 g of the additive in 500 milliliters of water in a beaker and stirring for 1 hour at 25°C. The additive solutions thus prepared were then coated onto paper by a dip coating process (both sides coated in one operation) by providing paper base sheets in cut sheet form ((8.5 × 11 inches) 21.6x27.9cm) in a thickness of 100 µm. Subsequent to air drying at 100°C for 10 minutes and monitoring the difference in weight prior to and subsequent to coating, the sheets were each coated on each side with 500 mg, in a thickness of 5 µm (total coating weight 1 g for two-sided sheets), of the additive composition For comparison purposes, an uncoated paper sheet treated with a composition containing only water by the same procedure was also imaged. The paper sheets thus prepared were incorporated into a Hewlett-Packard 500-C® color ink jet printer containing inks of the following composition: Cyan: Same as Example I. Magenta: Same as Example I. Yellow: Same as Example I. The black images were "process black" (i.e., formed by superimposition of cyan, magenta, and yellow images). The optical densities for the resulting images were as follows: Additive Optical Density black cyan magenta yellow none 1.08 1.18 1.03 0.80 2-pyrrolidone-5-carboxylic acid 0.99 1.00 0.82 0.72 1-aminopyrrolidine hydrochloride 1.29 1.07 1.12 0.90 L-prolinemethyl ester hydrochloride 1.04 1.05 0.87 0.68 1-(4-chlorobenzyl)-2-(1-pyrrolidinyl methyl) benzimidazole hydrochloride 1.07 1.12 0.96 0.77 2-piperidine methanol 1.01 1.11 0.87 0.64 2-piperidine carboxylic acid hydrochloride 1.01 1.01 0.78 0.67 1-benzyl-3-piperidine hydrochloride hydrate 1.23 1.20 1.11 0.90 2-iminopiperidine hydrochloride 1.35 1.17 1.13 0.78 4,4'-bipiperidine dihydrocloride 1.37 1.25 1.13 0.82 5,6,11,12-tetrahydro-dibenz [b,f] azocine dihydrochloride 0.97 1.09 0.92 0.76 2-(2-piperidino ethyl) pyridine 1.02 1.07 0.87 0.68 2-(2-methylamino ethyl) pyridine dihydrochloride 1.20 1.21 0.96 0.71 pyridoxamine dihydrochloride monohydrate 0.96 0.99 0.83 0.70 indole-2-carboxylic acid 0.98 1.07 0.63 0.70 indazole 1.00 1.11 0.96 0.71 tryptamine hydrochloride 1.24 1.09 0.93 0.89 Additive Optical Density black cyan magenta yellow harmane hydrochloride monohydrate (in methanol) 1.03 1.13 0.82 0.78 4-hydroxy quinoline 1.14 1.21 1.03 0.81 1,5-isoquinolinediol 1.01 1.11 0.76 075 1-isoquinoline carboxylic acid 1.03 1.13 0.83 0.70 8-hydroxy quinaldine 1.03 1.15 0.78 0.74 4-amino quinaldine 1.00 1.03 0.89 0.68 1,2,3,4-tetrahydro isoquinoline hydrochloride 1.07 1.16 0.99 0.76 1,2,3,4-tetrahydro-3-isoquinoline carboxylic acid hydrochloride 1.00 1.06 0.78 0.71 2-(chloromethyl quinoline) mono hydrochloride 0.96 1.03 0.73 0.73 8-ethoxy-5-quinoline sulfonic acid sodium salt hydrate 1.38 1.37 1.15 0.79 3-chloroquinuclidine hydrochloride 1.15 1.09 1.06 0.85 3-aminoquinuclidine dihydrochloride 1.24 1.18 1.10 0.74 3-quinuclidinol hydrochloride 1.30 1.21 1.08 0.81 3-quinuclidinone hydrochloride 1.20 1.27 1.05 0.78 neocuproine hydrochloride trihydrate 1.11 1.13 0.99 0.82 As the results indicate, the papers coated with the additive compositions exhibited acceptable optical densities for all colors.

Claims: A recording sheet which comprises a substrate, for example formed of paper or a transparent polymeric material, and an additive material applied on the substrate selected from the group consisting of pyrrole compounds, pyrrolidine compounds, pyridine compounds, piperidine compounds, homopiperidine compounds, quinoline compounds, isoquinoline compounds, quinuclidine compounds, indole compounds, indazole compounds, and mixtures thereof, with the proviso that the pyrrolidine compound is not a pyrrolidinone compound and the piperidine compound is not bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate, bis(1,2,2,6,5-pentamethyl-4-piperidyl) sebacate, 1-{2-[3-(3,5-di-t-butyl-4-hydroxy phenyl)propionyloxy]ethyl}-4-[3-(3,5-di-t-butyl-4-hydroxy phenyl) propionyloxy)-2,2,6,6-tetramethyl piperidine, 4-benzoyloxy-2,2,6,6-tetramethyl piperidine, 2-(3,5-di-t-butyl-4-hydroxy benzyl)-2-n-butylmalonate bis(1,2,2,6,6-pentamethyl-4-piperidyl), succinate bis(2,2,6,6-tetramethyl-4-piperidinyl) ester, a condensation polymer of dimethyl succinate and 1-(2-hydroxy ethyl)-4-hydroxy-2,2,6,6-tetramethyl piperidine, poly{[6-(1,1,3,3-tetramethylbutyl) amino-1,3,5-triazine-2,4-dyl][(2,2,6,6-tetramethyl-4-piperidyl) imino] hexamethylene [(2,2,6,6-tetramethyl-4-piperidyl)imino)}, a condensation polymer of N,N'-bis(3-aminopropyl) ethylene diamine and 2,4-bis[N-butyl-N-(1,2,2,6,6-pentamethyl-4-piperidyl)amino]-6-chloro-1,3,5-triazine or a compound represented oy the following formula wherein I is an integer of 4 - 10. A recording sheet according to claim 1, further including a binder, an antistatic agent, a biocide, and/or a filler. A recording sheet according to claim 1 or 2, wherein the additive material is present on the substrate in an amount of (1) from 1 to 50 percent by weight of the substrate, or (2) from 0.8 to 40 grams per square meter of the substrate. A recording sheet according to claim 1, 2 or 3, further comprising a binder, wherein the binder comprises (1) a polysaccharide, or (2) a quaternary acrylic copolymer latex. A recording sheet according to any of claims 1 to 4, including a binder, wherein the binder and the additive material (1) are present in relative amounts of from 10 percent by weight binder and 90 percent by weight additive material to 99 percent by weight binder and 1 percent by weight additive material, and/or (2) coated onto the substrate in a thickness of from 1 to 25 µm. A recording sheet according to any of the preceding claims wherein the additive is (A) a pyrrole compound, (B) a pyrrolidine compound, (C) selected from the group consisting of (1) 2-acetyl-pyrrole; (2) 2-acetyl-1-methylpyrrole; (3) 3-acetyl-1-methylpyrrole; (4) 3-acetyl-2,4-dimethylpyrrole; (5) pyrrole-2-carboxaldehyde; (6) pyrrole-2-carboxylic acid; (7) 3-carboxy-1,4-dimethyl-2-pyrroleacetic acid; (8) proline amide; (9) proline; (10) 1-(pyrrolidino carbonylmethyl) piperazine; (11) 2-pyrrolidone-5-carboxylic acid; (12) 3-pyrrolidino-1,2-propane diol; (13) 4-hydroxyproline; (14) 1,1'-ethylene bis (5-oxo-3-pyrrolidine carboxylic acid); (15) kainic acid monohydrate; and mixtures thereof, (D) a pyrrolidine acid salt compound, (E) selected from the group consisting of (1)1-amino pyrrolidine acid salts; (2) 2-(2-chloroethyl)-1-methyl pyrrolidine acid salts; (3) 1-(2-chloroethyl) pyrrolidine acid salts; (4) proline methyl ester acid salts; (5) tremorine acid salts; (6) ammonium pyrrolidine acid salts; (7) pyrrolidone acid salts; (8) 1-(4-chlorobenzyl)-2-(1-pyrrolidinyl methyl) benzimidazole acid salts; (9) billverdin acid salts; and mixtures thereof. A recording sheet according to any of claims 1 to 5 wherein the additive is (A) a pyridine compound selected from the group consisting of (1) 2,3-pyridine dicarboxylic acid; (2) 2,4-pyridine dicarboxylic acid monohydrate; (3) 2,5-pyridine dicarboxylic acid; (4) 2,6-pyridine dicarboxylic acid; (5) 3,4-pyridine dicarboxylic acid; (6) 3,5-pyridine dicarboxylic acid; (7) 2,6-pyridine dicarboxaldehyde; (8) 3,4-pyridine carboxamide; (9) 3,4-pyridine carboximide; (10) 2,3-pyridine carboxylic anhydride; (11) 3,4-pyridine carboxylic anhydride; (12) 2,6-pyridine methanol; (13) 2-pyridine ethane sulfonic acid; (14) 4-pyridine ethane sulfonic acid; (15) 3-pyridine sulfonic acid; (16) pyridoxic acid; (17) trans-3-(3-pyridyl) acrylic acid; (18) 2-pyridyl hydroxymethane sulfonic acid; (19) 3-pyridyl hydroxymethane sulfonic acid; (20) 6-methyl-2,3-pyridine dicarboxylic acid; (21) isonicotinic acid; (22) N,N-bis (2-hydroxyethyl) isonicotinamide; (23) 4,4'-trimethylene pyridine; (24) 2-(2-piperidinoethyl) pyridine; and mixtures thereof, (B) a pyridine acid salt compound, (C) selected from the group consisting of (1) pyridine acid salts; (2) 2-(chloromethyl) pyridine acid salts; (3) 2-pyridylacetic acid acid salts; (4) nicotinoyl chloride acid salts; (5) 2-hydrazinopyridine acid salts; (6) 2-(2-methyl aminoethyl) pyridine acid salts; (7) 1-methyl-1,2,3,6-tetrahydropyridine acid salts; (8) 2,6-dihydroxypyridine acid salts; (9) 3-hydroxy-2(hydroxymethyl) pyridine acid salts; (10) pyridoxine acid salts; (11) pyridoxal acid salts; (12) pyridoxal 5-phosphate acid salts; (13) 3-amino-2,6-dimethoxy pyridine acid salts; (14) pyridoxamine acid salts; (15) iproniazid acid salts; (16) tripelennamine acid salts; and mixtures thereof, (D) a piperidine compound, (E) selected from the group consisting of (1) 2-piperidine methanol; (2) 3-piperidine methanol; (3) 2-piperidine ethanol; (4) 4-piperidine ethanol; (5) 3-piperidino-1,2-propane diol; (6) 1-piperidine propionic acid; (7) 2-piperidine carboxylic acid; (8) 4-piperidinopiperidine; (9) 4-phenyl piperidine; (10) 2,2,6,6-tetramethyl piperidine; (11) 2-piperidone; (12) 1-methyl-4-(methylamino) piperidine; (13) 4,4'-trimethylene bis (1-methyl piperidine); (14) 4,4-trimethylene dipiperidine; (15) tris piperidinophosphine oxide; (16) 4,4-trimethylene bis (1-piperidine carboxamide); (17) 4,4'-trimethylene bis (1-piperidine propionitrile); (18) 4-methyl-2-(piperidinomethyl) phenol; (19) 1-methyl-4-piperidinyl bis (chlorophenoxy) acetate; and mixtures thereof. A recording sheet according to any of claims 1 to 5, wherein the additive is (A) a homopiperidine compound selected from the group consisting of (1) 2-(hexamethylene imino) ethyl chloride acid salts; (2) 3-(hexahydro-1 H-azepin-1-yl)-3'-nitropropiophenone acid salts; (3) imipramine acid salts; (4) carbamezepine; (5) 5,6,11,12-tetrahydro dibenz [b,f] azocine acid salts; and mixtures thereof, (B) a quinoline compound, (C) selected from the group consisting of (1) quinoline; (2) 2-hydroxyquinoline; (3) 4-hydroxy quinoline; (4) 5-hydroxy quinoline; (5) 8-hydroxy quinoline; (6) 3-amino quinoline; (7) 5-amino quinoline; (8) 6-amino quinoline; (9) 8-aminoquinoline; (10) 2-quinoline carboxylic acid; (11) 3-quinoline carboxylic acid; (12) 4-quinoline carboxylic acid; (13) 4-quinoline carboxaldehyde; (14) 2-quinoline thiol; (15) 2,4-quinoline diol; (16) quinaldine; (17) 8-hydroxyquinaldine; (18) 4-aminoquinaldine; (19) 2,6-dimethyl quinoline; (20) 2,7-dimethyl quinoline; (21) 4-methoxy-2-quinoline carboxylic acid; (22) 7,8-benzoquinoline; (23) methyl-2-phenyl-4-quinoline carboxylate; (24) 1,2,3,4-tetrahydro quinoline; (25) 6-ethoxy-1,2,3,4-tetrahydro-2,2,4-trimethyl quinoline; and mixtures thereof, (D) an isoquinoline compound, (E) selected from the group consisting of (1) 2-(N-butyl carbamoyl)-1,2,3,4-tetrahydro-isoquinoline; (2) 1-hydroxyisoquinoline; (3) 1-isoquinoline carboxylic acid; (4) 3-isoquinoline carboxylic acid; (5) 1,5-isoquinoline diol; and mixtures thereof, (F) selected from the group consisting of quinoline salt compounds and isoquinoline salt compounds, or (G) selected from the group consisting of (1) 8-hydroxyquinoline acid salts; (2) 5-amino-8-hydroxy quinoline acid salts; (3) 2-(chloromethyl) quinoline acid salts; (4) 8-hydroxyquinoline-5-sulfonic acid salts; (5) 8-ethoxy-5-quinoline sulfonic acid salts; (6) 1,2,3,4-tetrahydroisoquinoline acid salts; (7) 1,2,3,4-tetrahydro-3-isoquinoline carboxylic acid acid salts; (8) 6,7-dimethoxy-1,2,3,4-tetrahydro isoquinoline acid salts; (9) 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydro isoquinoline acid salts; (10) primaquine acid salts; (11) pentaquine acid salts; (12) dibucaine acid salts; (13) 9-aminoacridine acid salts; (14) 3,6-diamino acridine acid salts; (15) 2-quinoline thiol acid salts; (16) sparteine acid salts; (17) papaverine acid salts; (18) emetine acid salts; (19) 1,10-phenanthroline acid salts; (20) neocuproine acid salts; and mixtures thereof. A recording sheet according to any of claims 1 to 5, wherein the additive is (A) a quinuclidine compound, (B) selected from the group consisting of (1) quinuclidine acid salts; (2) 3-quinuclidinol acid salts; (3) 3-quinuclidinone acid salts; (4) 2-methylene-3-quinuclidinone acid salts; (5) 3-amino quinuclidine acid salts; (6) 3-chloro quinuclidine acid salts; (7) quinidine acid salts; (8) quinine acid salts; (9) quinine acid salts; (10) hydroquinidine acid salts; (11) hydroquinine acid salts; and mixtures thereof, (C)an indole compound, (D) selected from the group consisting of (1) indole; (2) 4,5,6,7-tetrahydroindole; (3) 3-indolemethanol; (4) 3-indole ethanol; (5) indole-3-carboxaldehyde; (6) 3-indolylacetate; (7) indole-3-acetamide; (8) indole-3-carboxylic acid; (9) indole-3-acetic acid; (10) 3-Indole propionic acid; (11) 3-indole acrylic acid; (12) 3-indole glyoxylic acid; (13) indole-3-pyruvic acid; (14) 3-indolelactic acid; (15) 3-indole butyric acid; (16) N-acetyl-tryptophanamide; (17) N-(3-indolylacetyl)-alanine; (18) N-(3-indolyl acetyl)-valine; (19) N-(3-indolyl acetyl)-isoleucine; (20) N-(3-indolyl acetyl)-leucine; (21) N-(3-indolyl acetyl)-aspartic acid; (22) N-(3-indolyl acetyl)-phenylalanine; (23) 4-hydroxyindole; (24) indole-4-carboxylic acid; (25) 4-indolyl acetate; (26) 4-methyl indole; (27) 5-hydroxy indole; (28) 5-hydroxy indole-3-acetic acid; (29) 5-hydroxy-2-indole carboxylic acid; (30) N-acetyl-5-hydroxytryptamine; (31) indole-5-carboxylic acid; (32) 5-methyl indole; (33) 5-methoxy indole; (34) indole-2-carboxylic acid; (35) indolene-2-carboxylic acid; (36) indole-2,3-dione; (37) 2-methyl indole; (38) 2,3,3-trimethyl indolenine; and mixtures thereof, (E) an indazole compound, (F)selected from the group consisting of (1) indazole; (2) 5-aminoindazole; (3) 6-aminoindazole; (4) 3-indazolinone; (5) N'-(6-indazolyl) sulfanilamide; (6) 4,5-dihydro-3-(4-pyridinyl)-2H-benz[g] indazole methane sulfonate; and mixtures thereof, (G) an indole salt compound, or (H) selected from the group consisting of (1) tryptamine acid salts; (2) 5-methyl tryptamine acid salts; (3) serotonin acid salts; (4) norharman acid salts; (5) harmane acid salts; (6) harmine acid salts; (7) harmaline acid salts; (8) harmol acid salts; (9) harmalol acid salts; (10) 3,6-diamino acridine acid salts; (11) S-(3-indolyl) isothiuronium salts; (12) yohimbine acid salts; (13) 4,5-dihydro-3-(4-pyridinyl)-2H-benz[g] indazole methane acid salts; and mixtures thereof. A process which comprises applying an aqueous recording liquid in an imagewise pattern to a recording sheet according to any of the preceding claims, the process preferably comprising (1) incorporating the recording sheet into an ink jet printing apparatus containing an aqueous ink and (2) causing droplets of the ink to be ejected in an imagewise pattern onto the recording sheet, thereby generating images on the recording sheet.

Inventors: MALHOTRA SHADI L, MALHOTRA, SHADI L.
Applicants: XEROX CORP, XEROX CORPORATION
Application year: 1995
Main classification: B41M5
IPC codes: B41M5